Featuring Serina Therapeutics’ CEO - Thursday, September 24, 2026

HUNTSVILLE, AL, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform^™ drug optimization technology enabling drug product candidates to treat neurological diseases and other indications, is pleased to announce that Serina’s CEO, Steven Ledger will present at Tribe Public’s Webinar Presentation and Q&A Event titled "A New Approach to Advanced Parkinson’s Disease: Serina Discusses SER-252’s Clinical Progress." The Event is scheduled to begin at 8:30 a.m. PST / 11:30 a.m. ET on Thursday, September 24, 2026. To register to join the complimentary event, please visit the Tribe Public LLC at AdvancingParkinsonsDisease.TribePublic.com.